Verweise von und zu Biologics in dermatology
Zurück zum ArtikelVerweise von anderen Artikeln
- Baricitinib
- Dmard
- Immunosuppressive drugs
- Janus kinase inhibitors
- Monoclonal antibodies
- Pseudo-sle syndrome
- Quantiferon tb gold test
- Rituximab
- Ustekinumab
Verweise zu anderen Artikeln
- Adalimumab
- Baricitinib
- Bimekizumab
- Braf inhibitors
- Brodalumab
- Certolizumab pegol
- Ciclosporin a
- Cytokine-release syndromes
- Dupilumab
- Efalizumab
- EGF receptor inhibitors
- Etanercept
- Golimumab
- Guselkumab
- Hand-foot syndrome
- Imatinib
- Immune checkpoint inhibitors
- Infliximab
- Ipilimumab
- Ixekizumab
- Jak inhibitors
- Mek inhibitors
- Neutrophilic eccrine hidradenitis
- Nivolumab
- Omalizumab
- Pasi
- Pembrolizumab
- Squamous cell carcinoma of the skin
- Pseudo-sle syndrome
- Psoriasis vulgaris
- Rituximab
- Secukinumab
- Sunitinib
- Tnf-alpha antagonists
- Tyrosine kinase inhibitors
- Tyrosine kinases
- Adverse drug reactions of the skin
- Ustekinumab
- Vismodegib
- Cytokines